» Articles » PMID: 33498905

Electrophysiology Read-Out Tools for Brain-on-Chip Biotechnology

Overview
Publisher MDPI
Date 2021 Jan 27
PMID 33498905
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Brain-on-Chip (BoC) biotechnology is emerging as a promising tool for biomedical and pharmaceutical research applied to the neurosciences. At the convergence between lab-on-chip and cell biology, BoC couples in vitro three-dimensional brain-like systems to an engineered microfluidics platform designed to provide an in vivo-like extrinsic microenvironment with the aim of replicating tissue- or organ-level physiological functions. BoC therefore offers the advantage of an in vitro reproduction of brain structures that is more faithful to the native correlate than what is obtained with conventional cell culture techniques. As brain function ultimately results in the generation of electrical signals, electrophysiology techniques are paramount for studying brain activity in health and disease. However, as BoC is still in its infancy, the availability of combined BoC-electrophysiology platforms is still limited. Here, we summarize the available biological substrates for BoC, starting with a historical perspective. We then describe the available tools enabling BoC electrophysiology studies, detailing their fabrication process and technical features, along with their advantages and limitations. We discuss the current and future applications of BoC electrophysiology, also expanding to complementary approaches. We conclude with an evaluation of the potential translational applications and prospective technology developments.

Citing Articles

Epileptiform activity in brain organoids derived from patient with Glucose Transporter 1 Deficiency Syndrome.

Muller Y, Lengacher L, Friscourt F, Quairiaux C, Stoppini L, Magistretti P Front Neurosci. 2024; 18:1498801.

PMID: 39605786 PMC: 11599213. DOI: 10.3389/fnins.2024.1498801.


Versatile micro-electrode array to monitor human iPSC derived 3D neural tissues at air-liquid interface.

Stoppini L, Heuschkel M, Loussert-Fonta C, Gomez Baisac L, Roux A Front Cell Neurosci. 2024; 18:1389580.

PMID: 38784710 PMC: 11112036. DOI: 10.3389/fncel.2024.1389580.


Current progress and challenges in the development of brain tissue models: How to grow up the changeable brain in vitro?.

Salmina A, Alexandrova O, Averchuk A, Korsakova S, Saridis M, Illarioshkin S J Tissue Eng. 2024; 15:20417314241235527.

PMID: 38516227 PMC: 10956167. DOI: 10.1177/20417314241235527.


Mind In Vitro Platforms: Versatile, Scalable, Robust, and Open Solutions to Interfacing with Living Neurons.

Zhang X, Dou Z, Kim S, Upadhyay G, Havert D, Kang S Adv Sci (Weinh). 2023; 11(11):e2306826.

PMID: 38161217 PMC: 10953569. DOI: 10.1002/advs.202306826.


Toward the Next Generation of Neural Iontronic Interfaces.

Forro C, Musall S, Montes V, Linkhorst J, Walter P, Wessling M Adv Healthc Mater. 2023; 12(20):e2301055.

PMID: 37434349 PMC: 11468917. DOI: 10.1002/adhm.202301055.


References
1.
Buzsaki G, Stark E, Berenyi A, Khodagholy D, Kipke D, Yoon E . Tools for probing local circuits: high-density silicon probes combined with optogenetics. Neuron. 2015; 86(1):92-105. PMC: 4392339. DOI: 10.1016/j.neuron.2015.01.028. View

2.
Kuijlaars J, Oyelami T, Diels A, Rohrbacher J, Versweyveld S, Meneghello G . Sustained synchronized neuronal network activity in a human astrocyte co-culture system. Sci Rep. 2016; 6:36529. PMC: 5098163. DOI: 10.1038/srep36529. View

3.
Taylor A, Dieterich D, Ito H, Kim S, Schuman E . Microfluidic local perfusion chambers for the visualization and manipulation of synapses. Neuron. 2010; 66(1):57-68. PMC: 2879052. DOI: 10.1016/j.neuron.2010.03.022. View

4.
Yamamoto H, Moriya S, Ide K, Hayakawa T, Akima H, Sato S . Impact of modular organization on dynamical richness in cortical networks. Sci Adv. 2018; 4(11):eaau4914. PMC: 6235526. DOI: 10.1126/sciadv.aau4914. View

5.
Jung G, Lee K, Park J, Choi S, Jeon W . Morphogenetic and neuronal characterization of human neuroblastoma multicellular spheroids cultured under undifferentiated and all-trans-retinoic acid-differentiated conditions. BMB Rep. 2013; 46(5):276-81. PMC: 4133894. DOI: 10.5483/bmbrep.2013.46.5.196. View